Cervical Cancer-Market Insights, Epidemiology and Market Forecast-2023- Japan

Publisher Name :
Date: 01-Jan-2017
No. of pages: 40
Price : Single User: US $ 1750  US $ 1488 Corporate User: US $ 5250  US $ 3675
This report is available at 15% Discount for Single User License and 30% Discount for Corporate Users License till 30 June 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Cervical Cancer- Market Insights, Epidemiology and Market Forecast-2023- Japan" Report provides marketed drugs information of Cervical Cancer. It includes historical and forecasted epidemiology and market size of the Cervical Cancer in Japan for 2013-2023. DelveInsight estimates that the therapeutic market size of Cervical Cancer in Japan will increase at a Compound Annual Growth Rate of 1.93% and reach up to USD 2.67 million by 2023. The global market size for prophylaxis treatment of Cervical Cancer is expected to grow at a CAGR of 0.71% and reach up to USD 2210.9 Million by 2023.

Cervical Cancer needs to be focused more and more because it adversely affects younger women. It is the fourth most common cause of death among women. Cervical Cancer occurs due to the uncontrolled growth of healthy cells in cervix and forms cervical lesions. It spreads to other tissues such as vagina and uterus. Cervical Cancer is caused by inheritance of defects or mutation in genes. Cervical cancer is also caused due to the infection by the Human Papilloma Virus (HPV) which can infect cells on the surface of the skin and those lining the genitals, anus, mouth and throat, but not the blood or internal organs such as the heart or lungs.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

• Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.

• Marketed information including available prescription drugs, its patent and exclusivity details.

• The Report also covers the detailed global historical and forecasted epidemiological data for Japan from 2013-2023.

• It also provides Market size of Cervical Cancer for Japan from 2013 and forecasted Market size to 2023.

• The report will help in developing business strategies by understanding the trends shaping and driving the Japan market size of the Cervical Cancer

• Identifying patient populations in the Japan market of Cervical Cancer to improve product design, pricing, and launch plans.

• To understand the future market competition in Japan Cervical Cancer therapeutics market, as well as prophylaxis and Insightful review of the key market drivers and barriers.

This report is available at 15% Discount for Single User License and 30% Discount for Corporate Users License till 30 June 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Cervical Cancer-Market Insights, Epidemiology and Market Forecast-2023- Japan

Table of Contents

Report Introduction
Cervical Cancer Disease Overview
Types of Cervical Cancer
Staging of Cervical Cancer
Pathophysiology
Etiology
Risk Factors of Cervical Cancer
Diagnosis of Cervical Cancer
Epidemiology and Patient Population of Cervical Cancer
Japan
Historical Incident Cases of Cervical Cancer in Japan (2013-2015)
Forecasted Incident Cases of Cervical Cancer in Japan (2016-2023)
Treatment Landscape
Treatment Algorithm
Treatment by Stages
Cervical Cancer Treatment Regimens
Current Unmet Needs
Cervical Cancer Emerging therapies Market Size
a) Bevacizumab (Avastin)
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
Avastin Historical Market Sales 2013-2015
Cost of therapy of Avastin
Cervical Cancer Prophylaxis Treatments
a) Cervarix (Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant)
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
Cervarix Historical Market Sales 2012-2015
Cost of therapy of Cervarix
b) Gardasil/ Gardasil 9
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
Gardasil Historical Market Sales 2012-2015
Cost of therapy of Gardasil
Pipeline Product (Phase III)
a) Z-100 (Ancer 20)
b) Axalimogene filolisbac or AXAL (ADXS11-001)
c) Gimeracil-Oteracil-Tegafur (S-1, TS-1)
Pipeline Product Analysis
Cervical Cancer Therapeutics Market in Japan
Historical market size of Japan (2013-2015)
Forecasted market size of Japan (2016-2023)
Cervical Cancer Prophylaxis Treatment Global
Historical Prophylaxis treatment market size (2013-2015)
Forecasted Prophylaxistreatment market size (2016-2023)
Market Drivers
Market Barriers
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1: Historical Incident Cases of Cervical Cancer in Japan (2013-2015)
Table 2: Forecasted Incident Cases of Cervical Cancer in Japan (2017-2023)
Table 3: Historical Cervical Cancer Therapeutics Market in Japan (2013-2015)
Table 4: Forecasted Cervical Cancer Therapeutics Market in Japan (2017-2023)
Table 5: Historical Cervical Cancer prophylaxis treatment global (2013-2015)
Table 6: Forecasted Cervical Cancer prophylaxis treatment global (2017-2023)

List of Figures

Figure 1: Pathophysiology of Cervical Cancer, 2017
Figure 2:Risk Factors of Cervical Cancer, 2017
Figure 3: Historical Incident Cases of Cervical Cancer in Japan (2013-2015)
Figure 4: Forecasted Incident Cases of Cervical Cancer in Japan (2017-2023)
Figure 5:Treatment Algorithm for Cervical Cancer, 2017
Figure 6:Treatment for patients with Stage IA1 of Cervical Cancer, 2017
Figure 7:Treatment for patients with Stage IA2 of Cervical Cancer, 2017
Figure 8:Treatment for patients with Stage IB1 of Cervical Cancer, 2017
Figure 9:Treatment for patients with Stage IB2 to Stage IVA of Cervical Cancer, 2017
Figure 10:Treatment for patients with Stage IVB of Cervical Cancer, 2017
Figure11: Historical Cervical Cancer Therapeutics Market in Japan (2013-2015)
Figure12: Forecasted Cervical Cancer Therapeutics Market in Japan (2017-2023)
Figure13: Historical Cervical Cancer prophylaxis treatment global (2013-2015)
Figure14: Forecasted Cervical Cancer prophylaxis treatment global (2017-2023)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Asia-Pacific Mitomycin C Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 22-Jun-2017        Price: US 4480 Onwards        Pages: 116
    This report studies the Mitomycin C market, Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.). Scope of the Report: This report focuses on the Mitomycin C in Asia-Pacific market, especially in Ch......
  • United States Capecitabine Market Report 2017
    Published: 20-Jun-2017        Price: US 3800 Onwards        Pages: 102
    In this report, the United States Capecitabine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Cap......
  • Asia-Pacific Paclitaxel Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 20-Jun-2017        Price: US 4480 Onwards        Pages: 123
    Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol". Scope of the Report: This report focuses on the Paclitaxel in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes......
  • Global Capecitabine Sales Market Report 2017
    Published: 14-Jun-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the global Capecitabine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Capecitabine for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - Sou......
  • Global Paclitaxel Injection Market Professional Survey Report 2017
    Published: 14-Jun-2017        Price: US 3500 Onwards        Pages: 117
    This report studies Paclitaxel Injection in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Bristol-Myers Squibb - Celgene Corporation - Hospira - Biologic......
  • Global Lymphoma Drugs Market 2017-2021
    Published: 07-Jun-2017        Price: US 3500 Onwards        Pages: 86
    Lymphoma is a type of cancer that affects the immune system of the body. Specifically, it affects the lymphocytes, a type of white blood cell. The lymphocytes are part of the immune system and help the body to fight infections. The cancerous lymphocytes grow uncontrollably and collect in different portions of the body; lymph node can be one of the most common sites for lymphoma development. The lymph nodes are found throughout the body particularly in the groin, neck, and under the arms. Lymp......
  • Asia-Pacific Cancer Treatment Drugs Market Report 2017
    Published: 05-Jun-2017        Price: US 4000 Onwards        Pages: 126
    In this report, the Asia-Pacific Cancer Treatment Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Cancer Treatment Drugs for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea......
  • Asia-Pacific Topotecan Hydrochloride Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 02-Jun-2017        Price: US 4480 Onwards        Pages: 124
    Topotecan Hydrochloride is the hydrochloride salt of a semisynthetic derivative of camptothecin with antineoplastic activity. During the S phase of the cell cycle, topotecan selectively stabilizes topoisomerase I-DNA covalent complexes, inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when complexes are encountered by the DNA replication machinery. Camptothecin is a cytotoxic quinoline-based alkaloid extracted fr......
  • Global Paclitaxel Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 19-May-2017        Price: US 3480 Onwards        Pages: 123
    Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it taxol. Scope of the Report: This report focuses on the Paclitaxel in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This repor......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs